Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Board/Management Information 2025

Jul 25, 2025

62142_rns_2025-07-25_a11e5aff-9d6e-4b4f-9aff-aecd2603dad1.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

Date : July 25, 2025

BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS

Sub: Outcome of Board Meeting

Dear Sir/Madam,

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) and other regulations, if applicable, we hereby inform the exchanges that the Board of Directors (“Board”) of the Company today i.e. July 25, 2025, has re-appointed Mr. Mark Saldanha (DIN: 00020983) as the Managing Director of the Company subject to approval of the shareholders at the forthcoming Annual General Meeting.

We request you to note the aforesaid in your records.

Thanking You,

Yours faithfully,

For Marksans Pharma Limited

Digitally signed by H PANIGRAHI DN: c=IN, o=Personal, title=5470, 2.5.4.20=b68fed9b4e54339fc79709c0767 H 3dbf0831efeaca440f7534fca8796f19bc37 a, postalCode=401107, st=Maharashtra, serialNumber=8504a87abeef17220e4e6f5 PANIGRAHI d37b003a37acd0ff57ca749f78aedfd26a26ce06c, cn=H PANIGRAHI Date: 2025.07.25 17:32:16 +05'30'

Harshavardhan Panigrahi Company Secretary

Enclosed as above

Annexure I

==> picture [5 x 74] intentionally omitted <==

==> picture [72 x 16] intentionally omitted <==

==> picture [93 x 16] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==

==> picture [47 x 46] intentionally omitted <==

==> picture [86 x 18] intentionally omitted <==

==> picture [111 x 18] intentionally omitted <==

Details pertaining to re-appointment of Mr. Mark Saldanha as Managing Director of Marksans Pharma Limited is given below:

Sr. No Particulars Details
1. Name of Director Mr. Mark Saldanha (DIN: 00020983)
2. Reason for Change viz.,
appointment, resignation, removal,
death or otherwise
Re-appointment as the Managing Director of the
Company for a further period of 5 years with
effect from 6thOctober 2025.
3. Date of Appointment & term of
appointment
Mr. Mark Saldanha (DIN: 00020983) has been
appointed as Managing Director, for a term of 5
years effective from 6thOctober, 2025 subject to
approval of the members of the Company and his
office shall not be liable to retire byrotation.
4. Brief Profile: He has over 24 years of experience in production,
marketing and finance. He is the principal
architect of the success and progress of the
Company. Under his able, dynamic and manifold
leadership, the Company rapidly growing to new
heights
of
success
and
higher
level
of
performance
5. Disclosure of relationships between
directors
Relative of Mrs. Sandra Saldanha

==> picture [5 x 74] intentionally omitted <==

==> picture [72 x 16] intentionally omitted <==

==> picture [93 x 16] intentionally omitted <==

==> picture [431 x 33] intentionally omitted <==